Anavex Life Sciences Corp (AVXL)

[Doc328]

That would be my assumption as well. Initiated in mid November 2023 and told eligible for centralized procedure announced a month later . So we are at 8 months now. I don't know why some people are stating the earliest is November 2024. EMA is slow but not that slow. Its a moot point as any application based on the single 2b/3 will be unlikely.

https://www.anavex.com/post/anavex-initiates-regulatory-submission-of-oral-blarcamesine-for-alzheimer-s-disease-to-european

https://www.globenewswire.com/news-release/2023/12/19/2798446/29248/en/Anavex-Received-Agreement-from-the-Committee-for-Medicinal-Products-for-Human-Use-CHMP-for-the-Submission-of-a-Marketing-Authorisation-Application-of-Oral-Blarcamesine-for-Alzheime.html